We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Developing QC Products for CF Testing

By Labmedica staff writers
Posted on 06 Apr 2005
An exclusive agreement has been signed by AcroMetrix Corp. More...
(Dallas, TX, USA) with the Children's Hospital Medical Center of Akron (CHMCA, OH, USA) to develop and commercialize quality control (QC) products for cystic fibrosis (CF) testing using CHMCA's new proprietary technology.

New recommendations and guidelines have been recommended by the American College of Medical Genetics and the American College of Obstetricians and Gynecologists for CF carrier testing in a population-based screening program. This screening for high-prevalence mutations using molecular diagnostic test methods identifies carrier couples with a one-in-four risk for affected offspring with each pregnancy, and offers them genetic counseling and various reproductive options. Because of the technical complexity of these tests, it is also recommended that laboratories conducting CF carrier screening comply with stringent quality assurance guidelines.

"This agreement with CHMCA will result in innovative quality control products designed to increase the accuracy and reliability of cystic fibrosis testing,” said Michael J. Eck, CEO of AcroMetrix. The company, which also has a facility in Alkmaar, The Netherlands, provides a line of molecular diagnostic quality control products that assist laboratories in meeting current government regulations and recommendations regarding quality assurance.





Related Links:
AcroMetrix

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.